The Multifaceted Nature of Tuberous Sclerosis Complex. [PDF]
Khan SA, Baig A, Riyami D.
europepmc +1 more source
ABSTRACT Background Improving care and research for individuals with genetic intellectual disabilities (GID) requires the identification and measurement of relevant patient reported outcomes (PROs). PROs represent the patient perspective on their health status.
Nadia Y. van Silfhout +5 more
wiley +1 more source
<i>TSC2</i> GAP Domain V1646Cfs*7 Variant Alters Protein Stability and Interaction Networks in Tuberous Sclerosis Complex. [PDF]
Utami KH +7 more
europepmc +1 more source
Intraoral Giant Cell Fibroma in a Young Patient with Tuberous Sclerosis Complex: A Case Report of a Rare Occurrence. [PDF]
D'souza OK, Naik R, Dukle S, Carvalho K.
europepmc +1 more source
GSK-J4 Suppresses Tumorigenesis by Targeting the PERK-c-Myc Pathway Through Endoplasmic Reticulum Stress Activation in Tuberous Sclerosis Complex. [PDF]
Lei X, Lang T, Li P, Wu C.
europepmc +1 more source
Clinical outcomes following stereotactic MRI-guided laser ablation in children with tuberous sclerosis complex and intractable epilepsy. [PDF]
Ortman C +23 more
europepmc +1 more source
Tuberous Sclerosis Complex-Associated Tubulointerstitial Kidney Disease. [PDF]
Sakhi H +7 more
europepmc +1 more source
Spatial gene expression profiling reveals the distinct microenvironment of tuberous sclerosis complex-associated angiomyolipoma. [PDF]
Watanabe R +6 more
europepmc +1 more source
Developmental Outcome at 36 Months in Tuberous Sclerosis: Are There any Modifiable Predictors? [PDF]
Joshi C.
europepmc +1 more source

